Publications:

---

Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation.

Experimental Hematology & Oncology

Moradabadi, Alireza A; Farsinejad, Alireza A; Khansarinejad, Behzad B; Fatemi, Ahamd A

Publication Date: 2019

Variant appearance in text: JAK2: C616Y

PubMed Link: 31165012

Variant Present in the following documents:

• Main text
• 40164_2019_Article_134.pdf

View BVdb publication page

---

Detection of Exon 12 and 14 Mutations in Janus Kinase 2 Gene Including a Novel Mutant in V617F Negative Polycythemia Vera Patients from Pakistan.

Journal Of Cancer

Akram, Afia Muhammad AM; Kausar, Humera H; Chaudhary, Asma A; Khalid, Ahmad Mukhtar AM; Shahzad, Muhammad Mudassar MM; Akhtar, Muhammad Waheed MW; Sabar, Muhammad Farooq MF; Sajid, Nadia N; Anazi, Nawaf Al NA; Aleem, Aamer A; Iqbal, Zafar Z

Publication Date: 2018

Variant appearance in text: JAK2: C616Y

PubMed Link: 30519338

Variant Present in the following documents:

• Main text
• jcav09p4341.pdf

View BVdb publication page

---

p.Y317H is a new JAK2 gain-of-function mutation affecting the FERM domain in a myelofibrosis patient with CALR mutation.

Haematologica

Eder-Azanza, Laura L; Hurtado, Cristina C; Navarro-Herrera, David D; Aranaz, Paula P; Novo, Francisco J FJ; Vizmanos, José L JL

Publication Date: 2017-08

Variant appearance in text: JAK2: C616Y

PubMed Link: 28473624

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technology.

Bmc Medical Genetics

Paradis, François W FW; Simard, Raynald R; Gaudet, Daniel D

Publication Date: 2010-04-01

Variant appearance in text: JAK2: C616Y

PubMed Link: 20359349

Variant Present in the following documents:

• Main text

View BVdb publication page

---

High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms.

The Journal Of Molecular Diagnostics : Jmd

Rapado, Inmaculada I; Grande, Silvia S; Albizua, Enriqueta E; Ayala, Rosa R; Hernández, José-Angel JA; Gallardo, Miguel M; Gilsanz, Florinda F; Martinez-Lopez, Joaquin J

Publication Date: 2009-03

Variant appearance in text: JAK2: C616Y

PubMed Link: 19225136

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.

Journal Of Cellular And Molecular Medicine

Tefferi, Ayalew A

Publication Date: 2009-02

Variant appearance in text: JAK2: C616Y

PubMed Link: 19175693

Variant Present in the following documents:

• Main text
• jcmm0013-0215.pdf

View BVdb publication page

---

Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia.

Cancer Research

Senyuk, Vitalyi V; Rinaldi, Ciro Roberto CR; Li, Donglan D; Cattaneo, Francesca F; Stojanovic, Aleksandra A; Pane, Fabrizio F; Du, Xiaoping X; Mahmud, Nadim N; Dickstein, Jerome J; Nucifora, Giuseppina G

Publication Date: 2009-01-01

Variant appearance in text: JAK2: C616Y

PubMed Link: 19118011

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders.

Leukemia

Walz, C C; Cross, N C P NC; Van Etten, R A RA; Reiter, A A

Publication Date: 2008-07

Variant appearance in text: JAK2: C616Y

PubMed Link: 18528425

Variant Present in the following documents:

• Main text

View BVdb publication page

---